Cargando…
Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic
Ebola virus (EBOV) is highly pathogenic, with a predisposition to cause outbreaks in human populations accompanied by significant mortality. An ovine polyclonal antibody therapy has been developed against EBOV, named EBOTAb. When tested in the stringent guinea pig model of EBOV disease, EBOTAb has b...
Autores principales: | Dowall, Stuart D., Bosworth, Andrew, Rayner, Emma, Taylor, Irene, Landon, John, Cameron, Ian, Coxon, Ruth, Al Abdulla, Ibrahim, Graham, Victoria A., Hall, Graham, Kobinger, Gary, Hewson, Roger, Carroll, Miles W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964638/ https://www.ncbi.nlm.nih.gov/pubmed/27465308 http://dx.doi.org/10.1038/srep30497 |
Ejemplares similares
-
Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product
por: Dowall, Stuart D., et al.
Publicado: (2017) -
Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection
por: Dowall, Stuart David, et al.
Publicado: (2016) -
Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model
por: Miller, Joanna L., et al.
Publicado: (2016) -
Investigating the Cellular Transcriptomic Response Induced by the Makona Variant of Ebola Virus in Differentiated THP-1 Cells
por: Bosworth, Andrew, et al.
Publicado: (2019) -
Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection
por: Qiu, Xiangguo, et al.
Publicado: (2012)